; Solvay SA (SOLB) - Financial and Strategic Analysis Review
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Solvay SA (SOLB) - Financial and Strategic Analysis Review

VIEWS: 74 PAGES: 39

Solvay SA (Solvay) is a global chemical and pharmaceutical company, operating in two sectors: Chemicals and Plastics. The chemicals sector specializes in soda ash, advanced functional minerals, electrochemistry, fluorinated products, hydrogen peroxide and persalts. Plastics sector specializes in specialty and vinyls. Its operations are spread across 5 continents, with a worldwide presence in 50 countries. The company is headquartered in Bruxelles, Belgium. In 2010, the company sold its Pharmaceutical business to Abbott for a total enterprise value of about €5.2 billion. Solvay SA Key Recent Developments May 11, 2010 Solvay Reports Net Sales Of EUR1.91 Billion For Q1 2010 Feb 18, 2010 Solvay Reports Net Sales Of EUR8.48 Billion For 2009 Feb 11, 2010 Solvay plans to build three RD&T centers in Asia Feb 11, 2010 Solvay Expands In Asia, Opens Three New R&D Technology Centers Feb 10, 2010 Solvay To Build Fuel Cell At SolVin's Plant In Antwerp, Belgium This comprehensive SWOT profile of Solvay SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including, - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of k

More Info
  • pg 1
									                   Solvay SA (SOLB) - Financial and Strategic Analysis Review

       Reference Code: GDPH40008FSA                                                                                      Publication Date: JUL 2010

       Rue de Prince Albert 33              Phone            +32 2 5096111                         Revenue            5,694 (million EUR)
       Bruxelles                            Fax              +32 2 5096617                         Net Profit         518 (million EUR)
       1050                                 Website          www.solvay.com                        Employees          19,000
       Belgium                              Exchange         SOLB [Euronext Brussels]              Industry           Pharmaceuticals & Healthcare

      Company Overview
       Solvay SA (Solvay) is a global chemical and pharmaceutical company, operating in two sectors: Chemicals and Plastics. The
       chemicals sector specializes in soda ash, advanced functional minerals, electrochemistry, fluorinated products, hydrogen
       peroxide and persalts. Plastics sector specializes in specialty and vinyls. Its operations are spread across 5 continents, with a
       worldwide presence in 50 countries. The company is headquartered in Bruxelles, Belgium. In 2010, the company sold its
       Pharmaceutical business to Abbott for a total enterprise value of about €5.2 billion.

      Key Executives                                                                 SWOT Analysis
                    Name                                   Title                     Solvay SA, SWOT Analysis
      Alois Michielsen                     Chairman                                  Strengths                          Weaknesses

      Bernard de Laguiche                  Chief Financial Officer
                                                                                     Wide Geographic Presence           Declining Revenues from
      Christian Jourquin                   Chief Executive Officer                                                      Plastics Segment
      Denis Solvay                         Vice Chairman                             Strong Growth Prospects
                                                                                                                        Sale of Pharmaceutical
      Jean-Marie Solvay                    Director                                                                     Business
      Source: Annual Report, Company Website, Primary and Secondary Research
      GlobalData
                                                                                     Opportunities                      Threats
      Share Data
      Solvay SA                                                                      Emerging Markets                   Government Regulations
       Share Price (EUR) as on 26-Jul-2010                               73.80
                                                                                     Strategic Acquisitions             Growing Parallel Trade
       EPS (EUR)                                                          2.62

       Market Cap (million EUR)                                          6,071

       Enterprise Value (million EUR)                                    7,811
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research
       Shares Outstanding (million)                                             82   GlobalData
       Source: Annual Report, Company Website, Primary and Secondary Research
       GlobalData

      Financial Performance                                                          Recent Developments
                                                                                     May 11, 2010         Solvay Reports Net Sales Of EUR1.91
                                                                                    
								
To top